WILLIAM COX: Open Payments
NPI 1184717936 · SELAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 46 payments from 11 companies in 2025. Trend: 2023 $917 · 2024 $1,432 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $859 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $244 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| Exact Sciences Corporation | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
Products named: AIRSUPRA, CAPLYTA, FARXIGA, BREZTRI, REXULTI, Kerendia, LEQVIO, INSPIRE.
Industry payments across WA — which companies pay providers there.
